A citation-based method for searching scientific literature

Ruben P A van Eijk, Marinus J C Eijkemans, Stavros Nikolakopoulos, Marc D Jansen, Henk-Jan Westeneng, Kristel R van Eijk, Rick A A van der Spek, Joke J F A van Vugt, Sanne Piepers, Geert-Jan Groeneveld, Jan H Veldink, Leonard H van den Berg, Michael A van Es. Pharmacogenomics J 2020
Times Cited: 7







List of co-cited articles
90 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials.
Ruben P A van Eijk, Ashley R Jones, William Sproviero, Aleksey Shatunov, Pamela J Shaw, P Nigel Leigh, Carolyn A Young, Christopher E Shaw, Gabriele Mora, Jessica Mandrioli,[...]. Neurology 2017
34
85

Amyotrophic lateral sclerosis.
Michael A van Es, Orla Hardiman, Adriano Chio, Ammar Al-Chalabi, R Jeroen Pasterkamp, Jan H Veldink, Leonard H van den Berg. Lancet 2017
401
71

Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.
Wouter van Rheenen, Aleksey Shatunov, Annelot M Dekker, Russell L McLaughlin, Frank P Diekstra, Sara L Pulit, Rick A A van der Spek, Urmo Võsa, Simone de Jong, Matthew R Robinson,[...]. Nat Genet 2016
265
71

Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.
Mariely DeJesus-Hernandez, Ian R Mackenzie, Bradley F Boeve, Adam L Boxer, Matt Baker, Nicola J Rutherford, Alexandra M Nicholson, NiCole A Finch, Heather Flynn, Jennifer Adamson,[...]. Neuron 2011
57

An estimate of amyotrophic lateral sclerosis heritability using twin data.
A Al-Chalabi, F Fang, M F Hanby, P N Leigh, C E Shaw, W Ye, F Rijsdijk. J Neurol Neurosurg Psychiatry 2010
166
57


Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.
Aude Nicolas, Kevin P Kenna, Alan E Renton, Nicola Ticozzi, Faraz Faghri, Ruth Chia, Janice A Dominov, Brendan J Kenna, Mike A Nalls, Pamela Keagle,[...]. Neuron 2018
225
57

The epidemiology of ALS: a conspiracy of genes, environment and time.
Ammar Al-Chalabi, Orla Hardiman. Nat Rev Neurol 2013
404
57

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Manuela Neumann, Deepak M Sampathu, Linda K Kwong, Adam C Truax, Matthew C Micsenyi, Thomas T Chou, Jennifer Bruce, Theresa Schuck, Murray Grossman, Christopher M Clark,[...]. Science 2006
42

Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis.
Janel O Johnson, Erik P Pioro, Ashley Boehringer, Ruth Chia, Howard Feit, Alan E Renton, Hannah A Pliner, Yevgeniya Abramzon, Giuseppe Marangi, Brett J Winborn,[...]. Nat Neurosci 2014
292
42

A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement.
Sylvie Bannwarth, Samira Ait-El-Mkadem, Annabelle Chaussenot, Emmanuelle C Genin, Sandra Lacas-Gervais, Konstantina Fragaki, Laetitia Berg-Alonso, Yusuke Kageyama, Valérie Serre, David G Moore,[...]. Brain 2014
264
42

A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.
Alan E Renton, Elisa Majounie, Adrian Waite, Javier Simón-Sánchez, Sara Rollinson, J Raphael Gibbs, Jennifer C Schymick, Hannu Laaksovirta, John C van Swieten, Liisa Myllykangas,[...]. Neuron 2011
42

Lithium lacks effect on survival in amyotrophic lateral sclerosis: a phase IIb randomised sequential trial.
Esther Verstraete, Jan H Veldink, Mark H B Huisman, Tim Draak, Esther V Uijtendaal, Anneke J van der Kooi, H Jurgen Schelhaas, Marianne de Visser, Ingeborg van der Tweel, Leonard H van den Berg. J Neurol Neurosurg Psychiatry 2012
50
42

Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial.
K E Morrison, S Dhariwal, R Hornabrook, L Savage, D J Burn, T K Khoo, J Kelly, C L Murphy, A Al-Chalabi, A Dougherty,[...]. Lancet Neurol 2013
84
42

Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS.
Hong Joo Kim, Nam Chul Kim, Yong-Dong Wang, Emily A Scarborough, Jennifer Moore, Zamia Diaz, Kyle S MacLea, Brian Freibaum, Songqing Li, Amandine Molliex,[...]. Nature 2013
865
42

Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?
Hiroshi Mitsumoto, Benjamin R Brooks, Vincenzo Silani. Lancet Neurol 2014
167
42

Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS.
Andrew C Elden, Hyung-Jun Kim, Michael P Hart, Alice S Chen-Plotkin, Brian S Johnson, Xiaodong Fang, Maria Armakola, Felix Geser, Robert Greene, Min Min Lu,[...]. Nature 2010
770
42

Widespread structural brain involvement in ALS is not limited to the C9orf72 repeat expansion.
Henk-Jan Westeneng, Renée Walhout, Milou Straathof, Ruben Schmidt, Jeroen Hendrikse, Jan H Veldink, Martijn P van den Heuvel, Leonard H van den Berg. J Neurol Neurosurg Psychiatry 2016
44
42

C9orf72-mediated ALS and FTD: multiple pathways to disease.
Rubika Balendra, Adrian M Isaacs. Nat Rev Neurol 2018
210
28

ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?
Dmitry Petrov, Colin Mansfield, Alain Moussy, Olivier Hermine. Front Aging Neurosci 2017
180
28

Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study.
Ammar Al-Chalabi, Andrea Calvo, Adriano Chio, Shuna Colville, Cathy M Ellis, Orla Hardiman, Mark Heverin, Robin S Howard, Mark H B Huisman, Noa Keren,[...]. Lancet Neurol 2014
173
28


Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial.
Julian Gold, Dominic B Rowe, Matthew C Kiernan, Steve Vucic, Susan Mathers, Ruben P A van Eijk, Avindra Nath, Marta Garcia Montojo, Gina Norato, Ulisses A Santamaria,[...]. Amyotroph Lateral Scler Frontotemporal Degener 2019
21
28

Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model.
Stefan Waibel, Alexander Reuter, Susanne Malessa, Eran Blaugrund, Albert C Ludolph. J Neurol 2004
79
28

Genome-wide analysis of the heritability of amyotrophic lateral sclerosis.
Margaux F Keller, Luigi Ferrucci, Andrew B Singleton, Pentti J Tienari, Hannu Laaksovirta, Gabriella Restagno, Adriano Chiò, Bryan J Traynor, Michael A Nalls. JAMA Neurol 2014
48
28

Expanded autologous regulatory T-lymphocyte infusions in ALS: A phase I, first-in-human study.
Jason R Thonhoff, David R Beers, Weihua Zhao, Milvia Pleitez, Ericka P Simpson, James D Berry, Merit E Cudkowicz, Stanley H Appel. Neurol Neuroimmunol Neuroinflamm 2018
62
28

Amyotrophic lateral sclerosis.
Orla Hardiman, Ammar Al-Chalabi, Adriano Chio, Emma M Corr, Giancarlo Logroscino, Wim Robberecht, Pamela J Shaw, Zachary Simmons, Leonard H van den Berg. Nat Rev Dis Primers 2017
393
28

Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs.
Jie Jiang, Qiang Zhu, Tania F Gendron, Shahram Saberi, Melissa McAlonis-Downes, Amanda Seelman, Jennifer E Stauffer, Paymaan Jafar-Nejad, Kevin Drenner, Derek Schulte,[...]. Neuron 2016
280
28

Transplantation of spinal cord-derived neural stem cells for ALS: Analysis of phase 1 and 2 trials.
Jonathan D Glass, Vicki S Hertzberg, Nicholas M Boulis, Jonathan Riley, Thais Federici, Meraida Polak, Jane Bordeau, Christina Fournier, Karl Johe, Tom Hazel,[...]. Neurology 2016
77
28

Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis.
Ki-Wook Oh, Chanil Moon, Hyun Young Kim, Sung-Il Oh, Jinseok Park, Jun Ho Lee, In Young Chang, Kyung Suk Kim, Seung Hyun Kim. Stem Cells Transl Med 2015
97
28

Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice.
Lindsay A Becker, Brenda Huang, Gregor Bieri, Rosanna Ma, David A Knowles, Paymaan Jafar-Nejad, James Messing, Hong Joo Kim, Armand Soriano, Georg Auburger,[...]. Nature 2017
233
28

Lithium carbonate in amyotrophic lateral sclerosis: lack of efficacy in a dose-finding trial.
A Chiò, G Borghero, A Calvo, M Capasso, C Caponnetto, M Corbo, F Giannini, G Logroscino, J Mandrioli, N Marcello,[...]. Neurology 2010
72
28

Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial.
Jeffrey M Statland, Dan Moore, Yunxia Wang, Maureen Walsh, Tahseen Mozaffar, Lauren Elman, Sharon P Nations, Hiroshi Mitsumoto, J Americo Fernandes, David Saperstein,[...]. Muscle Nerve 2019
13
28

Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.
Henk-Jan Westeneng, Thomas P A Debray, Anne E Visser, Ruben P A van Eijk, James P K Rooney, Andrea Calvo, Sarah Martin, Christopher J McDermott, Alexander G Thompson, Susana Pinto,[...]. Lancet Neurol 2018
157
28

Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.
Panayiota Petrou, Yael Gothelf, Zohar Argov, Marc Gotkine, Yossef S Levy, Ibrahim Kassis, Adi Vaknin-Dembinsky, Tamir Ben-Hur, Daniel Offen, Oded Abramsky,[...]. JAMA Neurol 2016
151
28

An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study.
Timothy M Miller, Alan Pestronk, William David, Jeffrey Rothstein, Ericka Simpson, Stanley H Appel, Patricia L Andres, Katy Mahoney, Peggy Allred, Katie Alexander,[...]. Lancet Neurol 2013
390
28

RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention.
Christopher J Donnelly, Ping-Wu Zhang, Jacqueline T Pham, Aaron R Haeusler, Nipun A Mistry, Svetlana Vidensky, Elizabeth L Daley, Erin M Poth, Benjamin Hoover, Daniel M Fines,[...]. Neuron 2013
580
28

Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial.
L Mazzini, I Ferrero, V Luparello, D Rustichelli, M Gunetti, K Mareschi, L Testa, A Stecco, R Tarletti, M Miglioretti,[...]. Exp Neurol 2010
255
28

Repeated Intrathecal Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis.
Ki-Wook Oh, Min-Young Noh, Min-Soo Kwon, Hyun Young Kim, Seong-Il Oh, Jinseok Park, Hee-Jin Kim, Chang-Seok Ki, Seung Hyun Kim. Ann Neurol 2018
38
28

Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II/III randomised controlled study.
Ryuji Kaji, Takashi Imai, Yasuo Iwasaki, Koichi Okamoto, Masanori Nakagawa, Yasuo Ohashi, Takao Takase, Takahisa Hanada, Hiroki Shimizu, Kunio Tashiro,[...]. J Neurol Neurosurg Psychiatry 2019
22
28

Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome.
Letizia Mazzini, Maurizio Gelati, Daniela Celeste Profico, Gianni Sorarù, Daniela Ferrari, Massimiliano Copetti, Gianmarco Muzi, Claudia Ricciolini, Sandro Carletti, Cesare Giorgi,[...]. Stem Cells Transl Med 2019
27
28

Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery.
Brian D Freibaum, Raghu K Chitta, Anthony A High, J Paul Taylor. J Proteome Res 2010
293
28

Mutations of optineurin in amyotrophic lateral sclerosis.
Hirofumi Maruyama, Hiroyuki Morino, Hidefumi Ito, Yuishin Izumi, Hidemasa Kato, Yasuhito Watanabe, Yoshimi Kinoshita, Masaki Kamada, Hiroyuki Nodera, Hidenori Suzuki,[...]. Nature 2010
844
28

TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis.
Jemeen Sreedharan, Ian P Blair, Vineeta B Tripathi, Xun Hu, Caroline Vance, Boris Rogelj, Steven Ackerley, Jennifer C Durnall, Kelly L Williams, Emanuele Buratti,[...]. Science 2008
28

Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients.
Koji Abe, Yasuto Itoyama, Gen Sobue, Shoji Tsuji, Masashi Aoki, Manabu Doyu, Chikuma Hamada, Kazuoki Kondo, Takatomo Yoneoka, Makoto Akimoto,[...]. Amyotroph Lateral Scler Frontotemporal Degener 2014
160
28

Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes.
Eva L Feldman, Nicholas M Boulis, Junguk Hur, Karl Johe, Seward B Rutkove, Thais Federici, Meraida Polak, Jane Bordeau, Stacey A Sakowski, Jonathan D Glass. Ann Neurol 2014
123
28

Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis.
S H Appel, J I Engelhardt, J S Henkel, L Siklos, D R Beers, A A Yen, E P Simpson, Y Luo, G Carrum, H E Heslop,[...]. Neurology 2008
94
28

Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia.
Axel Freischmidt, Thomas Wieland, Benjamin Richter, Wolfgang Ruf, Veronique Schaeffer, Kathrin Müller, Nicolai Marroquin, Frida Nordin, Annemarie Hübers, Patrick Weydt,[...]. Nat Neurosci 2015
474
28

The multistep hypothesis of ALS revisited: The role of genetic mutations.
Adriano Chiò, Letizia Mazzini, Sandra D'Alfonso, Lucia Corrado, Antonio Canosa, Cristina Moglia, Umberto Manera, Enrica Bersano, Maura Brunetti, Marco Barberis,[...]. Neurology 2018
67
28

NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results.
James D Berry, Merit E Cudkowicz, Anthony J Windebank, Nathan P Staff, Margaret Owegi, Katherine Nicholson, Diane McKenna-Yasek, Yossef S Levy, Natalie Abramov, Haggai Kaspi,[...]. Neurology 2019
29
28


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.